ST银江 reported revenue of ¥0.07B for the period ended 2026-06-30, -45.7% year on year. Net income was ¥-0.55B, a -836.3% net margin on a 0.8% gross margin. The largest revenue line is 智慧医疗 at 30% of the total. Free cash flow for the period was ¥-0.01B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.07B | -45.7% |
| Gross profit | ¥0.00B | — |
| Operating income | ¥-0.55B | — |
| Net income | ¥-0.55B | — |
| Gross margin | 0.8% | Net margin -836.3% |
| Revenue Q/Q | -71.4% | — |
| Segment | Revenue | Share |
|---|---|---|
| 智慧医疗 | ¥0.02B | 29.9% |
| 智慧城市 | ¥0.02B | 29.2% |
| 智慧交通 | ¥0.02B | 28.1% |
| 综合服务收入 | ¥0.01B | 8.0% |
| 基层治理 | ¥0.00B | 4.8% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.07B | 99.2% |
| R&D | ¥0.01B | 12.1% |
| SG&A | ¥0.06B | 86.0% |
| Tax & other | ¥-0.00B | -0.8% |
| Item | Amount |
|---|---|
| Total assets | ¥3.36B |
| Total liabilities | ¥2.51B |
| Shareholders' equity | ¥0.85B |
| Equity / assets | 25.3% |
| Operating cash flow | ¥-0.00B |
| Capital expenditure | ¥0.00B |
| Free cash flow | ¥-0.01B |
| Cash conversion (OCF / net income) | -2% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
大禹节水 ・ 吉峰科技 ・ 机器人 ・ 华星创业 ・ 红日药业 ・ ST华谊 ・ 阳普医疗 ・ 宝通科技 ・ 金龙机电 ・ 钢研高纳 ・ 中科电气 ・ 超图软件
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies